Crossmark

Transarterial chemoembolization of colorectal cancer liver metastasis: improved tumor response by DSM-TACE versus conventional TACE, a prospective, randomized, single-center trial

Crossref DOI link: https://doi.org/10.1007/s00330-020-07253-2

Published Online: 2020-09-22

Published Print: 2021-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Vogl, Thomas J.

Marko, Christian

Langenbach, Marcel C.

Naguib, Nagy N. N.

Filmann, Natalie

Hammerstingl, Renate

Gruber-Rouh, Tatjana
Funding

Funding for this research was provided by:

PharmaCept
License Information

Text and Data Mining valid from 2020-09-22

Version of Record valid from 2020-09-22
More Information

Article History

Received: 21 February 2020

Revised: 26 July 2020

Accepted: 31 August 2020

First Online: 22 September 2020

Compliance with ethical standards

:

: The scientific guarantor of this publication is Thomas J. Vogl.

: The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.

: Natalie Filmann kindly provided statistical advice for this manuscript.

: Written informed consent was obtained from all subjects (patients) in this study.

: Institutional Review Board approval was obtained.

: • prospective• randomized controlled trial• performed at one institution

Document is current

Any future updates will be listed below